Journal of Hepatology
Volume 51, Issue 5 , Pages 865-873, November 2009

Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats☆

  • Thomas Reiberger

      Affiliations

    • Department of Gastroenterology and Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • ,
  • Bernhard Angermayr

      Affiliations

    • Department of Gastroenterology and Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • ,
  • Philipp Schwabl

      Affiliations

    • Department of Gastroenterology and Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • ,
  • Natascha Rohr-Udilova

      Affiliations

    • Department of Gastroenterology and Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • ,
  • Markus Mitterhauser

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
    • ,
  • Alfred Gangl

      Affiliations

    • Department of Gastroenterology and Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • ,
  • Markus Peck-Radosavljevic

      Affiliations

    • Department of Gastroenterology and Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 1 404006589; fax: +43 1 404004735.

Received 24 February 2009; received in revised form 9 June 2009; accepted 18 June 2009. published online 04 August 2009.

Associate Editor: C. Merkel

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript and they do not have a relationship with the manufacturers of the drugs involved either in the past or present.

PII: S0168-8278(09)00518-2

doi:10.1016/j.jhep.2009.06.024

Journal of Hepatology
Volume 51, Issue 5 , Pages 865-873, November 2009

Article Tools

* Image Usage & Resolution